Jun 07, 2023
Immutep to Participate at the Jefferies Healthcare Conference
Jun 05, 2023
Immutep Reports Final Positive Data in 2nd Line Head and Neck Squamous Cell Carcinoma at ASCO 2023 Annual Meeting
Jun 02, 2023
Immutep Successfully Completes Institutional Placement and Institutional Component of its Entitlement Offer
May 29, 2023
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study
May 25, 2023
Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
